AcroMetrix announces the launch of the OptiQuant® BKV Quantification Panel
Benicia, CA, 18 Dec 2009
AcroMetrix, the leading provider of quality control materials in molecular diagnostics, announced today the launch of its OptiQuant BKV Quantification Panel. Designed to help laboratories assess the performance of molecular diagnostic test procedures for BK virus, this panel plays an important role in the management of transplant patients by assisting laboratories in providing quality diagnostic results.
“The OptiQuant BKV Quantification Panel further expands our transplant product menu and reinforces AcroMetrix’s position as a major player in providing Healthcare with essential quality control products. This panel is a key tool for laboratories in optimizing molecular BK virus assay performance and will ultimately improve the management of transplant patients,” says Michael J. Eck, President and CEO of AcroMetrix.
The OptiQuant BKV Quantification Panel is a vital component of a laboratory’s quality system. It allows laboratories to easily validate or verify a range of BK virus concentrations that encompasses the majority of patient samples due to its wide dynamic range. Additionally, the panel enables laboratories to verify the reliability of their BK virus assays over time, as it provides reproducible results from lot to lot. This superior consistency is result of the panel being manufactured in accordance with the ISO 17511 standard. Finally, to ensure that the laboratory controls the full process from extraction through amplification and detection, the panel members contain whole virus in an EDTA-based normal human plasma matrix that effectively mimics naturally occurring patient samples.
With the launch of the OptiQuant BKV Quantification Panel, AcroMetrix fulfills a market demand for standardized materials for molecular BK virus assays and continues to expand its portfolio of transplantation products. Convenient and ready to use, this standardized, serially diluted panel will help users establish or verify performance specifications for the linearity, accuracy, precision, reportable range, analytical sensitivity, and analytical specificity of their BK virus assays. It may also be used for training and proficiency testing of laboratory personnel. This product is for Research Use Only, not for use in diagnostic procedures.
OptiQuant is a registered trademark of AcroMetrix.
About AcroMetrix
AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that help laboratories meet quality requirements. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. For more information on AcroMetrix please visit the company web site at www.acrometrix.com.
Contact
Brian McLucas, T:707-746-8888x123,
.